Sather Financial Group Inc Has $229,000 Stock Position in Celsius Holdings Inc. $CELH

Key Points

• Sather Financial Group Inc has reduced its stake in Celsius Holdings Inc by 49.9%, now holding 4,932 shares valued at $229,000 as of the latest SEC filing.
• In the 2nd quarter, various hedge funds increased their positions or acquired new ones in Celsius, with institutional ownership reaching 60.95% of the company's stock.
• Several analysts have raised their target price for Celsius shares, with Needham & Company and Truist Financial both setting their new target at $70, maintaining a "buy" rating.

Sather Financial Group Inc decreased its holdings in shares of Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 49.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,932 shares of the company's stock after selling 4,911 shares during the quarter. Sather Financial Group Inc's holdings in Celsius were worth $229,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Fifth Third Wealth Advisors LLC acquired a new position in Celsius in the 2nd quarter valued at $229,000. SLT Holdings LLC grew its stake in Celsius by 40.8% in the 2nd quarter. SLT Holdings LLC now owns 16,690 shares of the company's stock valued at $774,000 after buying an additional 4,840 shares during the last quarter. Cyndeo Wealth Partners LLC acquired a new position in Celsius in the 2nd quarter valued at $359,000. E Fund Management Hong Kong Co. Ltd. acquired a new position in Celsius in the 2nd quarter valued at $148,000. Finally, US Bancorp DE grew its stake in Celsius by 36.6% in the 2nd quarter. US Bancorp DE now owns 17,645 shares of the company's stock valued at $819,000 after buying an additional 4,723 shares during the last quarter. Institutional investors and hedge funds own 60.95% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the stock. Needham & Company LLC raised their target price on shares of Celsius from $60.00 to $70.00 and gave the company a "buy" rating in a research note on Friday, September 5th. Truist Financial raised their target price on shares of Celsius from $65.00 to $70.00 and gave the company a "buy" rating in a research note on Monday, September 8th. Wall Street Zen lowered shares of Celsius from a "buy" rating to a "hold" rating in a research note on Sunday, August 17th. The Goldman Sachs Group started coverage on shares of Celsius in a research note on Thursday, September 11th. They issued a "buy" rating and a $72.00 target price on the stock. Finally, Jefferies Financial Group set a $72.00 price target on shares of Celsius and gave the stock a "buy" rating in a research report on Wednesday, September 3rd. Nineteen equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $63.15.

Insider Activity at Celsius

In other news, major shareholder Deborah Desantis sold 100,000 shares of the firm's stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the completion of the transaction, the insider directly owned 17,717,770 shares of the company's stock, valued at approximately $841,594,075. This trade represents a 0.56% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO John Fieldly sold 143,167 shares of the firm's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the transaction, the chief executive officer directly owned 895,410 shares of the company's stock, valued at $45,827,083.80. The trade was a 13.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 560,667 shares of company stock worth $27,240,162 in the last ninety days. Company insiders own 2.55% of the company's stock.

Celsius Stock Performance

NASDAQ CELH opened at $60.70 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.11 and a quick ratio of 1.76. The firm has a market capitalization of $15.66 billion, a price-to-earnings ratio of 164.05, a P/E/G ratio of 1.26 and a beta of 1.38. The company's fifty day moving average is $56.89 and its two-hundred day moving average is $45.97. Celsius Holdings Inc. has a 52-week low of $21.10 and a 52-week high of $64.81.

Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.24. The company had revenue of $739.30 million during the quarter, compared to the consensus estimate of $632.13 million. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The firm's revenue for the quarter was up 83.9% compared to the same quarter last year. During the same period last year, the firm earned $0.28 EPS. Equities research analysts forecast that Celsius Holdings Inc. will post 0.89 EPS for the current year.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.